Paper41300941
Microvascular Imaging of Hepatic Hemangiomas.
Baş H and 1 other. Diagnostics (Basel), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Microvascular Imaging of Hepatic Hemangiomas. Papers, record 41300941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11322212 | Vascularity of liver tumours and recent advances in doppler ultrasound. | J Hepatol | 2001 | https://conductscience.org/library/papers/11322212 | PubMed |
| 2 | 31759383 | Comparison of MicroFlow Imaging with color and power Doppler imaging for detecting and characterizing blood flow signals in hepatocellular carcinoma. | Ultrasonography | 2020 | https://conductscience.org/library/papers/31759383 | PubMed |
| 3 | 26102419 | Contrast-Enhanced Ultrasound of Focal Liver Lesions. | AJR Am J Roentgenol | 2015 | https://conductscience.org/library/papers/26102419 | PubMed |
| 4 | 27776663 | Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors. | Eur J Radiol | 2016 | https://conductscience.org/library/papers/27776663 | PubMed |
| 5 | 34721768 | New frontiers in liver ultrasound: From mono to multi parametricity. | World J Gastrointest Oncol | 2021 | https://conductscience.org/library/papers/34721768 | PubMed |
| 6 | 31888768 | Superb microvascular imaging technique in depicting vascularity in focal liver lesions: more hypervascular supply patterns were depicted in hepatocellular carcinoma. | Cancer Imaging | 2019 | https://conductscience.org/library/papers/31888768 | PubMed |
| 7 | 18833497 | Comments and illustrations regarding the guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS)--update 2008. | Ultraschall Med | 2008 | https://conductscience.org/library/papers/18833497 | PubMed |
| 8 | 25584708 | Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging. | Radiology | 2015 | https://conductscience.org/library/papers/25584708 | PubMed |
| 9 | 39795574 | Challenges in Diagnosing Focal Liver Lesions Using Contrast-Enhanced Ultrasound. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39795574 | PubMed |
| 10 | 33530676 | Benefits of contrast-enhanced ultrasonography for interventional procedures. | Ultrasonography | 2021 | https://conductscience.org/library/papers/33530676 | PubMed |
| 11 | 36860624 | Focal Liver Lesions other than Hepatocellular Carcinoma in Cirrhosis: Diagnostic Challenges. | J Transl Int Med | 2022 | https://conductscience.org/library/papers/36860624 | PubMed |
| 12 | 31270975 | Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging. | Korean J Radiol | 2019 | https://conductscience.org/library/papers/31270975 | PubMed |
| 13 | 31006227 | Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand? | Ultrasonography | 2019 | https://conductscience.org/library/papers/31006227 | PubMed |
| 14 | 36420572 | Microvascular flow imaging to differentiate focal hepatic lesions: the spoke-wheel pattern as a specific sign of focal nodular hyperplasia. | Ultrasonography | 2023 | https://conductscience.org/library/papers/36420572 | PubMed |
| 15 | 40764980 | Determination of redundant scan coverages along the Z-axis and dose implications for common paediatric computed tomography imaging examinations in a limited resource setting. | BMC Med Imaging | 2025 | https://conductscience.org/library/papers/40764980 | PubMed |
| 16 | 32731265 | Ultrasound 2020 - Diagnostics & Therapy: On the Way to Multimodal Ultrasound: Contrast-Enhanced Ultrasound (CEUS), Microvascular Doppler Techniques, Fusion Imaging, Sonoelastography, Interventional Sonography. | Rofo | 2021 | https://conductscience.org/library/papers/32731265 | PubMed |
| 17 | 37124492 | Morphometric analysis of tumor microvessels for detection of hepatocellular carcinoma using contrast-free ultrasound imaging: A feasibility study. | Front Oncol | 2023 | https://conductscience.org/library/papers/37124492 | PubMed |
| 18 | 17464990 | Contrast-enhanced ultrasound of histologically proven liver hemangiomas. | Hepatology | 2007 | https://conductscience.org/library/papers/17464990 | PubMed |
| 19 | 27382399 | An Innovative Ultrasound Technique for Evaluation of Tumor Vascularity in Breast Cancers: Superb Micro-Vascular Imaging. | J Breast Cancer | 2016 | https://conductscience.org/library/papers/27382399 | PubMed |
| 20 | 23745019 | Fortuitously discovered liver lesions. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23745019 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300941
GET https://conductscience.org/api/papers/v1/41300941/references?page=2